---
schema_version: "secwatch.filing_event.v1"
accession: "0001453687-23-000091"
form_type: "8-K"
ticker: "RNAC"
cik: "0001453687"
company_name: "Cartesian Therapeutics, Inc."
filed_at: "2023-11-27T23:59:59+00:00"
generated_at: "2026-06-07T21:26:06.157981+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Cartesian Therapeutics board member Scott D. Myers resigns effective Nov 21, 2023; not due to disagreement

## Summary
- Scott D. Myers resigned from the Board of Directors effective November 21, 2023.
- Resignation was to pursue other opportunities and not due to any disagreement with the Company.
- Myers also ceased service on the Compensation and Nominating and Corporate Governance Committees.
- The Company thanked Myers for his service since joining the board in June 2019.
- No replacement was announced; ticker RNAC listed on Nasdaq.

## SEC filing metadata
- accession: 0001453687-23-000091
- form_type: 8-K
- ticker: RNAC
- cik: 0001453687
- company_name: Cartesian Therapeutics, Inc.
- filed_at: 2023-11-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453687/000145368723000091/0001453687-23-000091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453687/000145368723000091/rnac-20231121.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001453687-23-000091
- JSON: https://secwatch.observer/filing/0001453687-23-000091.json
- Plain text: https://secwatch.observer/filing/0001453687-23-000091.txt

## Key facts
- Executive change
  Scott D. Myers resigned as member of the Board of Directors at Cartesian Therapeutics, Inc..
  - Action: resigned
  - Role: member of the Board of Directors
  source text: On November 21, 2023, Scott D. Myers, a member of the Board of Directors (the “Board”) of Cartesian Therapeutics, Inc. (the “Company”), notified the Company of his resignation from the Board, effective immediately, to pursue other opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453687/000145368723000091/0001453687-23-000091-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.